Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Molecular Insight Pharmaceuticals

Status: Terminated

Conditions: Paraganglioma; Pheochromocytoma

Study type: Observational

Funder types: Industry

Identifiers

NCT00911729

A1970

Details and patient eligibility

About

The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of two disease-specific questionnaires, and to evaluate how effective these questionnaires are at assessing the quality of life and symptoms of patients with pheochromocytoma or paraganglioma.

Enrollment: 24 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provide written informed consent and be willing to comply with protocol requirements
• Participant is aged ≥ 18
• Have a documented (medical record) diagnosis of either pheochromocytoma or paraganglioma with active symptoms or within 60 days of curative therapy

Exclusion criteria

Patient is currently asymptomatic from pheochromocytoma/paraganglioma diagnosis or duration > 60 days from curative therapy

• Participant has a clinically significant disorder, including alcohol or drug abuse, which may interfere with study participation or which may affect the outcome of the study as judged by the investigator.
• Participant has a mental disability or significant mental illness, legal incapacity or limited legal capacity or any other lack of fitness, in the investigator's opinion, to preclude the subject's participation in or ability to complete the study.
• Participant is currently too unwell to take part in the study.